NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-16 17:32இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Paushak Q2 FY27 PAT Rises 57% YoY to ₹13.51 Cr; Revenue Up 52% YoY to ₹89.32 Cr
Paushak reported strong Q2 FY27 performance with revenue from operations growing 52.0% YoY to ₹89.32 Cr compared to ₹58.78 Cr in Q2 FY26. Profit after tax rose 56.9% YoY to ₹13.51 Cr from ₹8.61 Cr, though it moderated 10.5% sequentially from ₹15.10 Cr in Q1 FY27. For H1 FY27, net profit expanded 38.6% YoY to ₹28.62 Cr on revenue of ₹172.87 Cr. The company's basic EPS for the quarter stood at ₹5.48, and net cash generated from operations strengthened to ₹40.72 Cr in H1 FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுPaushak reported its Q2 and H1 FY27 results, showing over 50% top-line growth driven by higher volume throughput.
ஏன் இது முக்கியம்Demonstrates commercialization and volume gains from recent downstream capex expansions, re-accelerating profit growth after a muted FY26.
Revenue from Operations (Q2): ₹8,932 lacsProfit After Tax (Q2): ₹1,351 lacsH1 FY27 Revenue: ₹17,287 lacsOperating Cash Flow (H1): ₹4,071.98 lacsH1 Revenue vs TTM Revenue: ~70%
📅 குறுகிய காலம்Earnings show strong YoY recovery and top-line momentum, which may be received positively despite slight QoQ net profit contraction.
📈 நீண்ட காலம்Operating leverage from the phosgene downstream expansions and 'China Plus One' positioning remains the primary multi-year growth driver.
⚠ அபாய எச்சரிக்கைகள்
Sequentially lower margins and PAT (QoQ PAT down 10.5%)
Significant rise in trade receivables to ₹77.18 Cr from ₹54.86 Cr as of March 2026
👀 கவனிக்க வேண்டியவை
Track capacity ramp-up from recent capital expenditure (CWIP reduced to ₹16.16 Cr) and monitor if operating margins hold up against chemical raw material price fluctuations.
Paushak Q1 FY27: Revenue Jumps 49.5% YoY to ₹83.55 Cr; PAT Up 25.5%
Paushak Limited delivered a strong performance for the quarter ended June 30, 2026, with revenue from operations surging 49.5% YoY to ₹83.55 Cr. Net profit grew 25.5% YoY to ₹15.10 Cr, despite a sharp 167% increase in raw material costs. The quarterly revenue is highly significant, representing approximately 38% of the company's total TTM revenue of ₹219 Cr. This scale-up suggests that the company's ₹240 Cr capacity expansion is beginning to reflect in the top-line performance.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has achieved a significant step-up in quarterly revenue, moving from a historical range of ₹49-59 Cr to over ₹83 Cr.
ஏன் இது முக்கியம்This performance validates the company's expansion strategy and its ability to capture 'China Plus One' demand in the niche phosgene-based specialty chemicals market.
Revenue (Q1 FY27): ₹83.55 கோடிPAT (Q1 FY27): ₹15.10 கோடிRevenue vs TTM Revenue: 38.1%YoY Revenue Growth: 49.5%YoY PAT Growth: 25.5%
📅 குறுகிய காலம்The stock is likely to react positively in the short term due to the substantial revenue beat and profit growth compared to historical averages.
📈 நீண்ட காலம்The structural shift toward higher volumes through capacity expansion is evident; long-term value will depend on maintaining margins while scaling semi-specialized products.
⚠ அபாய எச்சரிக்கைகள்
Sharp increase in raw material costs (up 167% YoY)
Potential margin compression from lower-margin semi-specialized products
Regulatory risks associated with phosgene gas manufacturing
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of this higher revenue run-rate and observe if operating margins stabilize as the company integrates its new downstream capacities.
Paushak Ltd FY26 Net Profit Rises 25.5% to ₹49.38 Cr; Declares ₹2.50 Dividend
Paushak Limited reported a strong financial performance for the year ended March 31, 2026, with annual revenue growing 26.7% to ₹210.95 crore. Net profit for the full year increased to ₹49.38 crore from ₹39.33 crore in the previous fiscal, reflecting healthy operational growth. The company maintained its profitability in Q4 with a PAT of ₹12.51 crore compared to ₹9.60 crore in the same quarter last year. Additionally, the Board has recommended a dividend of ₹2.50 per share, rewarding shareholders for the strong annual performance.
முக்கிய அம்சங்கள்
Annual Revenue from Operations increased by 26.7% YoY to ₹210.95 croreFull-year Net Profit (PAT) grew by 25.5% to ₹49.38 crore from ₹39.33 croreEarnings Per Share (EPS) rose to ₹20.03 for FY26 compared to ₹15.95 in FY25Recommended a dividend of ₹2.50 per equity share (50% of face value ₹5)Total Comprehensive Income for the year stood at ₹67.68 crore
👀 கவனிக்க வேண்டியவை
The company demonstrates robust double-digit growth in both revenue and profitability along with a consistent dividend payout. Investors should maintain a positive outlook given the strong EPS growth and healthy balance sheet.
Paushak Ltd to Appoint Jain Parkash as Whole-time Director for 3-Year Term
Paushak Limited has initiated a Postal Ballot process to seek shareholder approval for the appointment of Mr. Jain Parkash as a Whole-time Director. The proposed appointment is for a period of three years, effective from April 1, 2026. This is a Special Resolution, requiring a 75% majority for approval. Shareholders can cast their votes electronically between March 19, 2026, and April 17, 2026, with results expected by April 19, 2026.
முக்கிய அம்சங்கள்
Proposed appointment of Mr. Jain Parkash as Whole-time Director for a 3-year tenure starting April 1, 2026.The resolution is a Special Resolution, necessitating high shareholder consensus.E-voting period is set from March 19, 2026 (09:00 AM) to April 17, 2026 (05:00 PM).The cut-off date for determining voting eligibility was March 13, 2026.Final voting results will be announced on or before April 19, 2026.
👀 கவனிக்க வேண்டியவை
Investors should review the appointee's professional background in the explanatory statement to assess leadership quality. No immediate portfolio action is required as this is a standard governance procedure.
Paushak Limited has announced a leadership transition effective from the end of the 2025-26 fiscal year. Mr. Chintan Gosaliya will resign as Whole-time Director and COO on March 31, 2026, to pursue outside opportunities. To ensure continuity, the board has appointed Mr. Jain Parkash, the current Sr. VP of Operational Excellence, as a Whole-time Director for a three-year term starting April 1, 2026. Mr. Parkash brings over 30 years of specialized experience in specialty chemicals and pharma APIs to the role.
முக்கிய அம்சங்கள்
Mr. Chintan Gosaliya to step down as Whole-time Director and COO on March 31, 2026.Mr. Jain Parkash appointed as Whole-time Director for a 3-year term effective April 1, 2026.New appointee Mr. Parkash has 30+ years of experience in Specialty Chemicals and Agro-Chemicals.The appointment is an internal promotion and remains subject to shareholder approval via Special Resolution.
👀 கவனிக்க வேண்டியவை
Investors should monitor the transition for any shifts in operational strategy, though the internal promotion of an experienced executive suggests a focus on continuity.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Paushak Ltd Q3 FY26 PAT Drops 59% YoY to ₹6.17 Cr; Revenue Declines to ₹48.8 Cr
Paushak Limited reported a weak performance for the quarter ended December 31, 2025, with Net Profit (PAT) falling 59.5% YoY to ₹6.17 crore from ₹15.26 crore. Revenue from operations saw a marginal decline YoY to ₹48.80 crore but a significant 17% drop on a sequential (QoQ) basis. Profitability was severely impacted by a sharp reduction in Other Income, which fell from ₹6.31 crore to just ₹0.97 crore YoY. Additionally, the company made a provision of ₹1.01 crore towards new Labour Code implementations.
முக்கிய அம்சங்கள்
Revenue from Operations stood at ₹48.80 crore, down from ₹58.78 crore in the previous quarter (QoQ).Net Profit (PAT) declined sharply to ₹6.17 crore compared to ₹15.26 crore in Q3 FY25.Other Income dropped significantly to ₹0.97 crore from ₹6.31 crore in the corresponding quarter last year.Restated EPS for the quarter fell to ₹2.50 from ₹6.19 YoY, accounting for the 3:1 bonus issue and stock split.The company's equity shares were successfully listed on the National Stock Exchange (NSE) effective December 1, 2025.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces both sequential and year-on-year declines in top-line and bottom-line performance. The significant drop in other income and the impact of new labour provisions warrant a closer look at the core operating margins in upcoming quarters.
Paushak Ltd Commences Phased Production at New Rs 175 Cr Multi-Purpose Plant
Paushak Limited has initiated the phased commissioning of its new Multi-Purpose Plant for chemical derivatives and associated infrastructure. The project involves a significant investment of approximately Rs 175 crore, which is being funded through a combination of internal accruals and borrowings. This expansion is strategically designed to replace legacy manufacturing facilities and provide much-needed capacity enhancement, as existing facilities are currently optimally utilized. The full capacity from this expansion is expected to be added progressively over the next 12 months.
முக்கிய அம்சங்கள்
Investment of approximately Rs 175 crore in a new Multi-Purpose Plant for derivativesCommissioning process started in a phased manner to ensure smooth operational transitionProject rationale includes both replacement of legacy facilities and significant capacity enhancementProposed capacity to be fully integrated and added over the next 12 monthsFinancing structured through a mix of internal accruals and external borrowings
👀 கவனிக்க வேண்டியவை
Investors should view this as a significant growth catalyst that addresses current capacity constraints. Monitor the quarterly revenue trajectory over the next year to track the successful ramp-up of this new facility.
Paushak Limited CRISIL Rating Reaffirmed; Bank Facilities Enhanced to Rs 145 Crore
CRISIL Ratings has reaffirmed Paushak Limited's long-term credit rating at 'CRISIL A/Stable' and assigned a short-term rating of 'CRISIL A1'. The total rated bank loan facilities have been significantly increased from Rs 40 crore to Rs 145 crore. This enhancement includes a new term loan of Rs 70 crore and expanded working capital facilities totaling Rs 75 crore. The reaffirmation of the 'Stable' outlook indicates the company's maintained creditworthiness despite the higher debt capacity.
முக்கிய அம்சங்கள்
Long-term credit rating reaffirmed at 'CRISIL A/Stable' by CRISIL Ratings.Short-term credit rating of 'CRISIL A1' assigned for working capital facilities.Total bank loan facilities rated increased from Rs 40 crore to Rs 145 crore.New facilities include a Rs 70 crore Term Loan and Rs 75 crore in total Working Capital limits.The rating assignment covers both existing and proposed enhanced credit limits.
👀 கவனிக்க வேண்டியவை
The reaffirmation of a strong credit rating alongside a significant increase in borrowing limits suggests the company is well-positioned for expansion. Investors should monitor the deployment of the new Rs 70 crore term loan for capital expenditure or growth initiatives.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
